Source: Journal of acquired immune deficiency syndromes. Unidade: FM
Subjects: POLIMORFISMO, FARMACODINÂMICA, INFECÇÕES POR HIV (PATOLOGIA), COMORBIDADE, CINÉTICA, INTERFERONS (FARMACOLOGIA)
ABNT
ARAÚJO, Evaldo Stanislau Affonso de et al. Pharmacodynamics of PEG-IFN-ALFA-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients. Journal of acquired immune deficiency syndromes, v. 56, n. 2, p. 95-99, 2011Tradução . . Acesso em: 11 out. 2024.APA
Araújo, E. S. A. de, Dahari, H., Cotler, S. J., Layden, T. J., Neumann, A. U., Melo, C. E., & Barone, A. A. (2011). Pharmacodynamics of PEG-IFN-ALFA-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients. Journal of acquired immune deficiency syndromes, 56( 2), 95-99.NLM
Araújo ESA de, Dahari H, Cotler SJ, Layden TJ, Neumann AU, Melo CE, Barone AA. Pharmacodynamics of PEG-IFN-ALFA-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients. Journal of acquired immune deficiency syndromes. 2011 ; 56( 2): 95-99.[citado 2024 out. 11 ]Vancouver
Araújo ESA de, Dahari H, Cotler SJ, Layden TJ, Neumann AU, Melo CE, Barone AA. Pharmacodynamics of PEG-IFN-ALFA-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients. Journal of acquired immune deficiency syndromes. 2011 ; 56( 2): 95-99.[citado 2024 out. 11 ]